NPC in Chain Drug Review: Let’s Address Health System Improvements in 2019

In his latest column for Chain Drug Review, National Pharmaceutical Council President and Chief Executive Officer Dan Leonard looks deeper into 2019 and explores how we can take a more holistic approach toward addressing health care spending and getting it under control. Read the column to learn how value-based contracting, improved understanding of costs, reducing low-value care, and regulatory and legislative changes can help drive the health care system in the United States toward greater value for all stakeholders.

>> Learn more in the latest issue of Chain Drug Review.